OrganOx today announced the completion of its acquisition by Terumo in a deal valued at approximately $1.5 billion.
OXFORD, England and MADISON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd. today announced the completion of its acquisition by Terumo Corporation, following satisfaction of all customary ...
Hosted on MSN
Terumo completes $1.5bn acquisition of OrganOx
The technology is approved in Australia, Canada, Europe, and the US, and has been used in more than 6,000 liver transplants.
Pharmaceutical Technology on MSN
Seres to obtain $3.6m from CARB-X for SER-155 development
In a placebo-controlled, randomised Phase Ib trial, the therapy demonstrated a 77% reduction in bacterial BSIs against ...
McGill University researchers 3D print hydrogels directly onto vocal cords using one of the smallest bioprinters in the world.
“Some studies show that niacinamide and vitamins C, D, and E may help protect against UV damage,” says Dr. Moy. “Antioxidants ...
This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results